The current stock price of ZYXI is 0.125 USD. In the past month the price decreased by -82.88%. In the past year, price decreased by -98.48%.
ChartMill assigns a fundamental rating of 2 / 10 to ZYXI. ZYXI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months ZYXI reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS decreased by -540.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -163.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed ZYXI and the average price target is 2.91 USD. This implies a price increase of 2225.6% is expected in the next year compared to the current price of 0.125.
For the next year, analysts expect an EPS growth of -1584.67% and a revenue growth -52.33% for ZYXI
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.72 | 214.47B | ||
| ISRG | INTUITIVE SURGICAL INC | 63 | 192.28B | ||
| BSX | BOSTON SCIENTIFIC CORP | 30.5 | 133.37B | ||
| SYK | STRYKER CORP | 27.59 | 138.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.46 | 59.52B | ||
| IDXX | IDEXX LABORATORIES INC | 56.45 | 56.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.81 | 48.94B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.06 | 37.76B | ||
| RMD | RESMED INC | 26.37 | 38.11B | ||
| DXCM | DEXCOM INC | 37.28 | 27.05B | ||
| PODD | INSULET CORP | 62.58 | 20.12B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 17.59B |
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
ZYNEX INC
9655 Maroon Circle
Englewood COLORADO 80112 US
CEO: Thomas Sandgaard
Employees: 1000
Phone: 18004956670
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
The current stock price of ZYXI is 0.125 USD. The price decreased by -34.9% in the last trading session.
ZYXI does not pay a dividend.
ZYXI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ZYXI stock is listed on the Nasdaq exchange.
The next ex-dividend date for ZYNEX INC (ZYXI) is January 5, 2022.
ZYNEX INC (ZYXI) has a market capitalization of 3.80M USD. This makes ZYXI a Nano Cap stock.